NM_152743.4:c.1791G>A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 2P and 13B. PM2BP4_StrongBP6_Very_StrongBP7
The NM_152743.4(BRAT1):c.1791G>A(p.Leu597Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000745 in 1,598,252 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.000046   (  0   hom.,  cov: 34) 
 Exomes 𝑓:  0.000077   (  0   hom.  ) 
Consequence
 BRAT1
NM_152743.4 synonymous
NM_152743.4 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.305  
Publications
1 publications found 
Genes affected
 BRAT1  (HGNC:21701):  (BRCA1 associated ATM activator 1) The protein encoded by this ubiquitously expressed gene interacts with the tumor suppressing BRCA1 (breast cancer 1) protein and and the ATM (ataxia telangiectasia mutated) protein. ATM is thought to be a master controller of cell cycle checkpoint signalling pathways that are required for cellular responses to DNA damage such as double-strand breaks that are induced by ionizing radiation and complexes with BRCA1 in the multi-protein complex BASC (BRAC1-associated genome surveillance complex). The protein encoded by this gene is thought to play a role in the DNA damage pathway regulated by BRCA1 and ATM. [provided by RefSeq, Mar 2012] 
BRAT1 Gene-Disease associations (from GenCC):
- neonatal-onset encephalopathy with rigidity and seizuresInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, ClinGen, G2P, Labcorp Genetics (formerly Invitae)
- neurodevelopmental disorder with cerebellar atrophy and with or without seizuresInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77). 
BP6
Variant 7-2538744-C-T is Benign according to our data. Variant chr7-2538744-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 540179.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BP7
Synonymous conserved (PhyloP=-0.305 with no splicing effect.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000460  AC: 7AN: 152238Hom.:  0  Cov.: 34 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
7
AN: 
152238
Hom.: 
Cov.: 
34
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.000104  AC: 24AN: 231388 AF XY:  0.000118   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
24
AN: 
231388
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000775  AC: 112AN: 1446014Hom.:  0  Cov.: 68 AF XY:  0.0000778  AC XY: 56AN XY: 719724 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
112
AN: 
1446014
Hom.: 
Cov.: 
68
 AF XY: 
AC XY: 
56
AN XY: 
719724
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
33472
American (AMR) 
 AF: 
AC: 
0
AN: 
44716
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26126
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39692
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
86254
European-Finnish (FIN) 
 AF: 
AC: 
32
AN: 
37874
Middle Eastern (MID) 
 AF: 
AC: 
1
AN: 
5766
European-Non Finnish (NFE) 
 AF: 
AC: 
75
AN: 
1111832
Other (OTH) 
 AF: 
AC: 
4
AN: 
60282
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.462 
Heterozygous variant carriers
 0 
 9 
 18 
 26 
 35 
 44 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000460  AC: 7AN: 152238Hom.:  0  Cov.: 34 AF XY:  0.0000403  AC XY: 3AN XY: 74370 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
7
AN: 
152238
Hom.: 
Cov.: 
34
 AF XY: 
AC XY: 
3
AN XY: 
74370
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41460
American (AMR) 
 AF: 
AC: 
0
AN: 
15288
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5196
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4834
European-Finnish (FIN) 
 AF: 
AC: 
3
AN: 
10620
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
4
AN: 
68048
Other (OTH) 
 AF: 
AC: 
0
AN: 
2094
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.525 
Heterozygous variant carriers
 0 
 1 
 2 
 2 
 3 
 4 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
Neonatal-onset encephalopathy with rigidity and seizures    Benign:1 
Aug 02, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:1 
May 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
BRAT1: BP4 -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.